Abbott Laboratories shares were falling ahead of the opening bell on Monday after a jury found the company had failed to warn that its premature baby formula could increase infants’ risk of developing a potentially deadly bowel illness.
July 29, 2024 - 14:07
By Pharos Investment Advisors Comments are Off
Abbott Laboratories shares were falling ahead of the opening bell on Monday after a jury found the company had failed to warn that its premature baby formula could increase infants’ risk of developing a potentially deadly bowel illness.
Regulated by Hellenic Capital Market Commission
with Registration Number 5/700/10.12.2014
Copyright 2023©. All Rights Reserved